348 related articles for article (PubMed ID: 9422802)
1. Synthesis of kininogen and degradation of bradykinin by PC12 cells.
Dendorfer A; Wellhöner P; Braun A; Roscher AA; Dominiak P
Br J Pharmacol; 1997 Dec; 122(8):1585-92. PubMed ID: 9422802
[TBL] [Abstract][Full Text] [Related]
2. Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens.
Stuardo M; Gonzalez CB; Nualart F; Boric M; Corthorn J; Bhoola KD; Figueroa CD
J Leukoc Biol; 2004 Apr; 75(4):631-40. PubMed ID: 14742641
[TBL] [Abstract][Full Text] [Related]
3. Degradation of bradykinin by bovine tracheal epithelium and isolated epithelial cells.
Dendorfer A; Vordermark D; Dominiak P
Br J Pharmacol; 1997 Jan; 120(1):121-9. PubMed ID: 9117086
[TBL] [Abstract][Full Text] [Related]
4. Release of endothelial-derived kallikrein, kininogen and kinins.
Nolly H; Nolly A
Biol Res; 1998; 31(3):169-74. PubMed ID: 9830504
[TBL] [Abstract][Full Text] [Related]
5. Expression and cellular localization of the kallikrein-kinin system in human ocular tissues.
Ma JX; Song Q; Hatcher HC; Crouch RK; Chao L; Chao J
Exp Eye Res; 1996 Jul; 63(1):19-26. PubMed ID: 8983960
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin increases catecholamine release via B2 receptors.
Dendorfer A; Häuser W; Falias D; Dominiak P
Pflugers Arch; 1996; 432(3 Suppl):R99-106. PubMed ID: 8994550
[TBL] [Abstract][Full Text] [Related]
7. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide activates the kallikrein-kinin system in mouse choroid plexus cell line ECPC4.
Takano M; Satoh C; Kunimatsu N; Otani M; Hamada-Kanazawa M; Miyake M; Ming K; Yayama K; Okamoto H
Neurosci Lett; 2008 Apr; 434(3):310-4. PubMed ID: 18329172
[TBL] [Abstract][Full Text] [Related]
9. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
Imamura T; Dubin A; Moore W; Tanaka R; Travis J
Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
[TBL] [Abstract][Full Text] [Related]
10. Primary structures of guinea pig high- and low-molecular-weight kininogens.
Semba U; Umeda Y; Shibuya Y; Okabe H; Tanase S; Yamamoto T
Int Immunopharmacol; 2004 Oct; 4(10-11):1391-400. PubMed ID: 15313436
[TBL] [Abstract][Full Text] [Related]
11. The kininogen gene family in obstructive uropathy.
El-Dahr SS
Semin Nephrol; 1998 Nov; 18(6):633-40. PubMed ID: 9819154
[TBL] [Abstract][Full Text] [Related]
12. T-kininogen, processing and functions.
Greenbaum LM; Howard E; Albus U; Lapp C; Gao XX
Agents Actions Suppl; 1992; 38 ( Pt 1)():300-6. PubMed ID: 1281610
[TBL] [Abstract][Full Text] [Related]
13. Possible protective effects of kinins and converting enzyme inhibitors in cardiovascular tissues.
Nolly H; Miatello R; Damiani MT; Abate CD
Immunopharmacology; 1997 Jun; 36(2-3):185-91. PubMed ID: 9228545
[TBL] [Abstract][Full Text] [Related]
14. Kinin generation from exogenous kininogens at the surface of retinoic acid-differentiated human neuroblastoma IMR-32 cells after stimulation with interferon-γ.
Guevara-Lora I; Majkucinska M; Barbasz A; Faussner A; Kozik A
Peptides; 2011 Jun; 32(6):1193-200. PubMed ID: 21549779
[TBL] [Abstract][Full Text] [Related]
15. Cellular localization of low-molecular-weight kininogen and bradykinin B2 receptor mRNAs in human kidney.
Song Q; Wang DZ; Harley RA; Chao L; Chao J
Am J Physiol; 1996 Jun; 270(6 Pt 2):F919-26. PubMed ID: 8764310
[TBL] [Abstract][Full Text] [Related]
16. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
[TBL] [Abstract][Full Text] [Related]
17. The synthesis and distribution of the kinin B1 and B2 receptors are modified in the hippocampus of rats submitted to pilocarpine model of epilepsy.
Argañaraz GA; Silva JA; Perosa SR; Pessoa LG; Carvalho FF; Bascands JL; Bader M; da Silva Trindade E; Amado D; Cavalheiro EA; Pesquero JB; da Graça Naffah-Mazzacoratti M
Brain Res; 2004 Apr; 1006(1):114-25. PubMed ID: 15047030
[TBL] [Abstract][Full Text] [Related]
18. Myeloperoxidase-catalyzed oxidative inactivation of human kininogens: the impairment of kinin-precursor and prekallikrein-binding functions.
Kozik A; Golda A; Mak P; Suder P; Silberring J; Barbasz A; Rapala-Kozik M
Biol Chem; 2011 Mar; 392(3):263-74. PubMed ID: 21194373
[TBL] [Abstract][Full Text] [Related]
19. A possible alternative mechanism of kinin generation in vivo by cathepsin L.
Puzer L; Vercesi J; Alves MF; Barros NM; Araujo MS; Aparecida Juliano M; Reis ML; Juliano L; Carmona AK
Biol Chem; 2005 Jul; 386(7):699-704. PubMed ID: 16207091
[TBL] [Abstract][Full Text] [Related]
20. A second expressed kininogen gene in mice.
Shesely EG; Hu CB; Alhenc-Gelas F; Meneton P; Carretero OA
Physiol Genomics; 2006 Jul; 26(2):152-7. PubMed ID: 16837654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
